Back
Krystal Biotech, Inc. 10K Form
Buy
74
KRYS
Krystal Biotech, Inc.
Last Price:
$221.80
Seasonality Move:
4.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KRYS News And Ratings
See the #1 stock for the next 7 days that we like better than KRYS
KRYS Financial Statistics
Sales & Book Value
| Annual Sales: | $290.5M |
|---|---|
| Cash Flow: | $38M |
| Price / Cash Flow: | 39.99 |
| Annual Sales: | $39.26 |
| Price / Book: | 5.66 |
Profitability
| EPS (TTM): | 6.66700 |
|---|---|
| Net Income (TTM): | $198.9M |
| Gross Margin: | $263.7M |
| Return on Equity: | 19.91% |
| Return on Assets: | 18.11% |
Krystal Biotech, Inc. Earnings Forecast
Key Krystal Biotech, Inc. Financial Ratios
-
The Gross Profit Margin over the past 9 years for KRYS is 90.77%.
-
The Selling, General & Administrative Expenses for KRYS have been equal to 39.13% of Gross Profit Margin.
-
The Research & Development expenses have been 18.44% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of KRYS is 30.69% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 3 years.
Krystal Biotech, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | KRYS |
| CUSIP: | 501147 |
| Website: | krystalbio.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 10.14 |
| Quick Ratio: | 9.43 |
Price-to-Earnings
| Trailing P/E Ratio: | 74.04 |
|---|---|
| Forward P/E Ratio: | 26.72 |
KRYS Technical Analysis vs Fundamental Analysis
Buy
74
Krystal Biotech, Inc. (KRYS)
is a Buy
Is Krystal Biotech, Inc. a Buy or a Sell?
-
Krystal Biotech, Inc. stock is rated a BuyThe current Krystal Biotech, Inc. [KRYS] share price is $221.96. The Score for KRYS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.